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Brief Correspondence

Can Exercise Adaptations Be Maintained in Men with Prostate
Cancer Following Supervised Programmes? Implications to the
COVID-19 Landscape of Urology and Clinical Exercise
Pedro Lopez a,b,*, Dennis R. Taaffe a,b, Robert U. Newton a,b,c, Nigel Spry a,b,d,
Tom Shannon e, Mark Frydenberg f, Fred Saad g, Daniel A. Galvão a,b
Exercise medicine clinics have had to change their services
including those for men with prostate cancer (PCa) due to
the recent coronavirus disease 2019 (COVID-19) where faceto-face supervised exercise programmes are required to
cease. Unsupervised home-based (ie, off-site) interventions
are an alternative method to improve physical activity
behaviour in different clinical populations; however,
despite being superior to usual care [1], benefits derived
from these programmes are modest compared with face-toface clinic-based programmes and not sustained for
prolonged periods in men with PCa at different stages of
disease [1,2]. Moreover, it is undetermined whether a
change in programme delivery (ie, face-to-face clinic-based
to unsupervised home-based programmes) would preserve
clinical outcomes. These outcomes are relevant as the gains
achieved with supervised periods of exercise could be
significantly reduced, resulting in loss of exercise adaptations and decline in psychological and metabolic health.
In this brief correspondence, we analyse the effects of
change from face-to-face supervised to unsupervised
home-based exercise programmes on fatigue, quality of
life (QoL), and body composition in men with PCa. Although
none of the studies were performed during a viral
pandemic, we highlight and contextualise our findings to
their application for the COVID-19 pandemic, where faceto-face interventions have been restricted. This information
will help provide a rationale for the delivery of exercise
medicine to PCa patients in clinical practice in the current
COVID-19 landscape.
A systematic review was undertaken in randomised
controlled trials (RCTs) evaluating the effects of supervised
resistance-based exercise programmes with subsequent
change to a nonsupervised exercise intervention in PCa
patients. Data were extracted from four manuscripts [3–6]
describing three RCTs in men with PCa on androgen

suppression therapy (AST) or previously treated with AST,
which included fatigue, QoL, and body composition (ie, fat
and lean mass) from the completion of face-to-face
supervised and unsupervised home-based periods. The
study selection procedure and results, and the main
characteristics are described in the Supplementary material
and provided in Table 1. We undertook a meta-analysis
using a random-effect model and the Hartung-Knapp-SidikJonkman method. Pooled-effect estimates were obtained
from within-group values. Statistical heterogeneity was
assessed using the Cochran Q test and expressed by I2.
One-third of men undergoing AST experience fatigue due
to associated depression, anxiety, pain, and insomnia,
resulting in reduced QoL. Despite the maintenance of
patient-reported outcomes during unsupervised homebased programmes (Fig. 1A and 1B), issues related to the
participants’ baseline levels and programme design may
affect the interpretation of our findings. In the included
studies, participants mostly presented with low baseline
levels of fatigue and high levels of QoL, and this may have
attenuated further change from the exercise programme
during the unsupervised period. Thus, we may need to
consider that fatigue and QoL are likely to be affected during
the pandemic period in patients with higher fatigue levels
and poor QoL. This concern is not only because of the
distress associated with time on AST or fears related to
tumour recurrence, but also because of distancing from
family and friends, and fears associated with the COVID-19
pandemic. Moreover, most unsupervised home-based
programmes require participants to have a self-controlled
physical activity habit. Although this might work for those
with regular exercise habits, it is unlikely to be generalised
to all patients. Thus, current unsupervised models based on
a usual weekly exercise volume (eg, 150 min/wk) or selfdirected physical activity may not fit patient needs during
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Fig. 1 – Mean difference and standard mean difference effects of face-to-face exercise programmes compared with unsupervised home-based exercise
programmes on (A) fatigue, (B) quality of life, (C) fat mass, and (D) lean mass. Squares represent study-specific estimates and diamonds represent
pooled estimates of random-effect meta-analysis. CI = confidence interval.

the COVID-19 pandemic. A redesigned home-based exercise
programme leveraging the rapidly developing technology
resources may help facilitate and assist participants in
overcoming barriers related to exercise practice, such as
lack of self-discipline, safety and monitoring, time, and
treatment-related fatigue. Digital health facilitating technology might include the following:
1 Wearable biosensors (eg, heart rate, physical activity,
steps, and distance)
2 Digital exercise prescription platforms providing the
exercise programme and instructions, and recording
exercises completed on the patient’s smart device or
computer
3 Video chat with a qualified exercise professional to
monitor and support the patient
During face-to-face supervised exercise, studies reported
positive effects on body fat (range: –2.6 to –0.6 kg) and lean
mass (range: 0.1–0.7 kg) [3,5,6]. However, our analysis
reveals that PCa patients were more likely to increase fat
mass during follow-ups with unsupervised programmes,
although lean mass was preserved (Fig. 1C and 1D).
Considering the maintenance of physical activity levels
and nutritional status reported in those studies [3,6], our
findings suggest that body fat is likely to be increased
during COVID-19 restriction, potentially adversely affecting
metabolic health and disease prognosis [7]. Although there
is evidence that patients on AST may be less likely to
develop COVID-19 than PCa patients not receiving AST [8],

poor body composition and reduced physical activity levels
can contribute to poorer disease prognosis, altering
systemic and cellular factors and increasing the incidence
of comorbidities such as diabetes or hypertension [9]. Thus,
our results highlight the need for different exercise
strategies such as an adequate increase of exercise stimulus
(volume or intensity) to balance energy expenditure during
physical activity restrictions or for facilitating intervention
delivery as outlined above using different resources such as
exercise smartphone Apps and online programmes (eg,
telehealth). This may help provide instructions and
feedback to help maintain patient motivation during the
outbreak and avoid physical inactivity. Therefore, a higher
exercise stimulus and increased contact with patients are
likely to help maintain exercise adherence and counteract
expected weight gain during self-quarantine [10].
In summary, despite the relatively small number of
studies and patients in our meta-analysis, the direction of
our results and the change of habits during the lockdown
[10] are a concern when viewed in the context of the current
worldwide situation. Changing from face-to-face to unsupervised self-directed home-based exercise programmes is
unlikely to provide further benefits on fatigue, QoL, and
body composition in patients with PCa during physical
distancing restrictions, but may help with maintenance.
Therefore, use of various technologies to keep patients
motivated during self-quarantine and an increase in
exercise stimulus to counteract physical distancing restrictions are some of our suggestions for the current COVID-19
landscape to avoid physical inactivity. These measures are
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Table 1 – Study characteristics: cancer therapy duration, demographic and clinical characteristics, sample size, supervised and
nonsupervised exercise prescription, and outcomes assessed.
Author
(year)

Cancer therapy
duration

Demographical and
clinical characteristics

Galvão et al
(2014) [3]

Previous AST
duration of 12 mo
with time since its
cessation of 38 mo

Age: 71.4 yr;
II–IV;
Previous AST and
radiotherapy

Taaffe et al
(2017) [4] b

Minimum
exposure to AST of
2 mo and
anticipated to
receive AST for the
subsequent 12 mo

Ndjavera et al
(2020) [5]

Patients with
newly diagnosed
prostate cancer and
beginning AST
treatment

Age: 68.8 yr;
Localised and nodal
metastases;
Gleason score: 7.8;
AST AST plus radiotherapy
AST plus antiandrogen AST
plus surgery
Age: 72.0 yr;
Locally advanced and
metastatic patients;
Gleason score range from
6 to 10;
ASTAST plus radiotherapy

Newton et al
(2019) [6] b

Minimum
exposure to AST of
2 mo and
anticipated to
receive AST for the
subsequent 12 mo

Age: 69.0 yr;
Localised and nodal
metastases;
Gleason score: 7.8;
AST AST plus radiotherapy
AST plus antiandrogen

Face-to-face supervised
exercise period

Unsupervised homebased exercise period

Outcomes

Combined resistance and
aerobic training:
n = 50, 2 sessions per week
for 24 wk; RT: 2–4 sets of
6–12
RM; AT: 20–30 min at 70–
85% HR
Combined resistance and
aerobic training:
n = 54, 2 sessions per week
for 24 wk; AT: 20–30 min
at
60–85% HR; RT: 2–4 sets of
6–12 RM
Combined resistance and
aerobic training:
n = 24, 2 sessions per week
for 12 wk; AT: 6 bouts of
5 min
at 55–85% HR; RT: 2–4 sets
of 10 reps at 11–15 RPE
Combined resistance and
aerobic training:n = 50,
2 sessions per week for
24 wk; AT: 20–30 min at
60–85% HR; RT: 2–4 sets of
6–12 RM

24 wk; booklet with
detailed information about
a home exercise
prescription including
resistance, aerobic, and
ﬂexibility exercises

Fat mass, lean
mass, SF-36 a

24 wk; home-based
programme that
recommended 150 min of
aerobic exercise per week
and resistance exercise
using body weight and
resistance bands
12 wk; patients were
instructed to continue
exercising and maintain
self-directed levels of
physical activity

EORTC QLQC30Fatigue c

24 wk; home-based
programme that
recommended 150 min of
aerobic exercise per week
and resistance exercise
using body weight and
resistance bands

Fat mass,
FACT-P a,
FACIT-Fatigue
c

Fat mass, lean
mass

AST = androgen suppression therapy; AT = aerobic training; EORTC QLQ-C30 = European Organisation for Research and Treatment of Cancer Quality of Life
Questionnaire C30; FACIT = Functional Assessment of Chronic Illness Therapy; FACT-P = Functional Assessment of Cancer Therapy—Prostate; HR = hear rate;
RM = repetitions maximum; RPE = rate of perceived exertion; RT = resistance training; SF-36 = 36-Item Short Form Survey.
a
Included in quality-of-life meta-analysis.
b
Papers derived from the same trial.
c
Included in fatigue meta-analysis.
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stock ownership or options, expert testimony, royalties, or patents ﬁled,
received, or pending), are the following: None.

Author contributions: Pedro Lopez had full access to all the data in the

Funding/Support and role of the sponsor: Pedro Lopez is supported by

study and takes responsibility for the integrity of the data and the

the National Health and Medical Research Council (NHMRC) Centre of

accuracy of the data analysis.

Research Excellence (CRE) in Prostate Cancer Survivorship Scholarship.
Daniel A. Galvão and Robert U. Newton are funded by an NHMRC CRE in

Study concept and design: Lopez, Taaffe, Newton, Galvão.
Acquisition of data: Lopez.
Analysis and interpretation of data: Lopez, Taaffe, Newton, Spry, Shannon,
Frydenberg, Saad, Galvão.
Drafting of the manuscript: Lopez, Taaffe, Newton, Spry, Shannon,

Prostate Cancer Survivorship. The results of the study are presented
clearly, honestly, without fabrication, falsiﬁcation, or inappropriate data
manipulation. Sponsors were not involved in the study design, analysis
or interpretation of data, manuscript writing, and decision to submit the
manuscript for publication.

Frydenberg, Saad, Galvão.
Critical revision of the manuscript for important intellectual content:

Appendix A. Supplementary data

Lopez, Taaffe, Newton, Spry, Shannon, Frydenberg, Saad, Galvão.
Statistical analysis: Lopez.
Obtaining funding: None.
Administrative, technical, or material support: None.
Supervision: None.
Other: None.

Supplementary material related to this article can be
found, in the online version, at doi:https://doi.org/10.1016/j.
euros.2020.09.002.
References

Financial disclosures: Pedro Lopez certiﬁes that all conﬂicts of interest,

[1] Buffart LM, Kalter J, Sweegers MG, et al. Effects and moderators of

including speciﬁc ﬁnancial interests and relationships and afﬁliations

exercise on quality of life and physical function in patients with

relevant to the subject matter or materials discussed in the manuscript

cancer: an individual patient data meta-analysis of 34 RCTs. Cancer

(eg, employment/afﬁliation, grants or funding, consultancies, honoraria,

Treat Rev 2017;52:91–104.

50

E U RO P EA N U ROL OGY OP E N S C I E NC E 21 ( 20 20 ) 47 –5 0

[2] Galvão DA, Newton RU, Girgis A, et al. Randomized controlled trial

[10] Zachary Z, Brianna F, Brianna L, et al. Self-quarantine and weight

of a peer led multimodal intervention for men with prostate cancer

gain related risk factors during the COVID-19 pandemic. Obes Res

to increase exercise participation. Psychooncology 2018;27:199–

Clin Pract 2020;14:210–6.

207.
[3] Galvão DA, Spry N, Denham J, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical

a

Exercise Medicine Research Institute, Edith Cowan University, Perth,

functioning in men with prostate cancer previously treated with

Western Australia, Australia

androgen suppression and radiation from TROG 03.04 RADAR. Eur

b

School of Medical and Health Sciences, Edith Cowan University, Perth,

Urol 2014;65:856–64.

Western Australia, Australia

[4] Taaffe DR, Newton RU, Spry N, et al. Effects of different exercise

c

School of Human Movement and Nutrition Sciences, University of

modalities on fatigue in prostate cancer patients undergoing an-

Queensland, St. Lucia, Queensland, Australia

drogen deprivation therapy: a year-long randomised controlled

d

Faculty of Medicine, University of Western Australia, Nedlands, Western

trial. Eur Urol 2017;72:293–9.

Australia, Australia

[5] Ndjavera W, Orange ST, O’Doherty AF, et al. Exercise-induced at-

e

The Prostate Clinic, Hollywood Private Hospital, Nedlands, Western

tenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a

Australia, Australia
f

Department of Surgery, Faculty of Medicine, Nursing and Health Sciences,

randomised controlled trial. BJU Int 2020;125:28–37.
[6] Newton RU, Galvão DA, Spry N, et al. Exercise mode speciﬁcity for
preserving spine and hip bone mineral density in prostate cancer

Monash University, Clayton, Victoria, Australia
g

Division of Urology and Urologic Oncology, Centre Hospitalier de
l'Université de Montréal, Montreal, Quebec, Canada

patients. Med Sci Sports Exerc 2019;51:607–14.
[7] King AJ, Burke LM, Halson SL, Hawley JA. The challenge of main-

*Corresponding author. Exercise Medicine Research Institute, Edith

taining metabolic health during a global pandemic. Sports Med

Cowan University, 270 Joondalup Drive, Joondalup WA 6027, Australia.

2020;50:1233–41.
[8] Montopoli M, Zumerle S, Vettor R, et al. Androgen-deprivation
therapies for prostate cancer and risk of infection by SARS-CoV2: a population-based study (N = 4532). Ann Oncol 2020;31:1040–5.
[9] Smith MR, Saad F, Egerdie B, et al. Sarcopenia during androgendeprivation therapy for prostate cancer. J Clin Oncol 2012;30:3271–6.

Tel. +61 416463228.
E-mail address: plopezda@our.ecu.edu.au (P. Lopez).

